tirzepatide vs semaglutide weight loss study vs. for loss—what's the difference? 🤔Both have become very popular, but knowing which one is right for you matters. Semaglutide boosts gut health and reduces inflammation, while Tirzepatide controls comparative effectiveness of semaglutide and

Now you see celebrities (such as Kim Kardashian) endorsing them and Instagram ads promoting them, and these medications have continued to capture a larger market share, driven by their robust clinical profiles

Cotadutide (MEDI0382) is the most extensively developed dual GLP-1/glucagon receptor agonist, showing significant improvements in glucose control, BW (likely mediated by reduced energy intake rather than increased energy expenditure), hepatic fat, and albuminuria in a small RCT on patients with T2D and overweight or obesity 45,46

A study that investigated the effects of insulin and GLP-1RAs (exenatide and dulaglutide) on BMD over a 52-week duration gathered 70 individuals with type 2 diabetes

For patients who may benefit from GLP-1based therapies but face cost or availability barriers, it may be valuable to explore whether alternative regulatory mechanisms could help balance safety oversight with broader access